These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

844 related articles for article (PubMed ID: 29121279)

  • 1. Clinical and preclinical perspectives on Chemotherapy-Induced Peripheral Neuropathy (CIPN): a narrative review.
    Flatters SJL; Dougherty PM; Colvin LA
    Br J Anaesth; 2017 Oct; 119(4):737-749. PubMed ID: 29121279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-induced painful neuropathy: pain-like behaviours in rodent models and their response to commonly used analgesics.
    Hopkins HL; Duggett NA; Flatters SJL
    Curr Opin Support Palliat Care; 2016 Jun; 10(2):119-128. PubMed ID: 27054288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Chemotherapy-Induced Peripheral Neuropathy: Systematic Review and Recommendations.
    Hou S; Huh B; Kim HK; Kim KH; Abdi S
    Pain Physician; 2018 Nov; 21(6):571-592. PubMed ID: 30508986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine Stress Axis-Dependence of Duloxetine Analgesia (Anti-Hyperalgesia) in Chemotherapy-Induced Peripheral Neuropathy.
    Staurengo-Ferrari L; Bonet IJM; Araldi D; Green PG; Levine JD
    J Neurosci; 2022 Jan; 42(3):405-415. PubMed ID: 34880120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms, Predictors, and Challenges in Assessing and Managing Painful Chemotherapy-Induced Peripheral Neuropathy.
    Kanzawa-Lee GA; Knoerl R; Donohoe C; Bridges CM; Smith EML
    Semin Oncol Nurs; 2019 Jun; 35(3):253-260. PubMed ID: 31053396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beyond symptomatic relief for chemotherapy-induced peripheral neuropathy: Targeting the source.
    Ma J; Kavelaars A; Dougherty PM; Heijnen CJ
    Cancer; 2018 Jun; 124(11):2289-2298. PubMed ID: 29461625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives.
    Poupon L; Kerckhove N; Vein J; Lamoine S; Authier N; Busserolles J; Balayssac D
    Expert Opin Drug Saf; 2015 Aug; 14(8):1269-82. PubMed ID: 26058312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy-Induced Peripheral Neuropathy: Causative Agents, Preventative Strategies, and Treatment Approaches.
    Kachrani R; Santana A; Rogala B; Pawasauskas J
    J Pain Palliat Care Pharmacother; 2020 Sep; 34(3):141-152. PubMed ID: 32118502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy-induced peripheral neuropathy: prevention and treatment.
    Pachman DR; Barton DL; Watson JC; Loprinzi CL
    Clin Pharmacol Ther; 2011 Sep; 90(3):377-87. PubMed ID: 21814197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duloxetine prevents bortezomib and paclitaxel large-fiber chemotherapy-induced peripheral neuropathy (LF-CIPN) in sprague dawley rats.
    Mansooralavi N; Khomula EV; Levine JD
    Mol Pain; 2023; 19():17448069231185694. PubMed ID: 37338165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy-induced peripheral neuropathy.
    Fehrenbacher JC
    Prog Mol Biol Transl Sci; 2015; 131():471-508. PubMed ID: 25744683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Practical Approaches to Chemotherapy-Induced Neuropathic Pain: Prevention, Assessment, and Treatment.
    Majithia N; Loprinzi CL; Smith TJ
    Oncology (Williston Park); 2016 Nov; 30(11):1020-9. PubMed ID: 27854104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage Toll-like Receptor 9 Contributes to Chemotherapy-Induced Neuropathic Pain in Male Mice.
    Luo X; Huh Y; Bang S; He Q; Zhang L; Matsuda M; Ji RR
    J Neurosci; 2019 Aug; 39(35):6848-6864. PubMed ID: 31270160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy-induced peripheral neuropathy: where are we now?
    Colvin LA
    Pain; 2019 May; 160 Suppl 1(Suppl 1):S1-S10. PubMed ID: 31008843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention and treatment of chemotherapy-induced peripheral neuropathy.
    Piccolo J; Kolesar JM
    Am J Health Syst Pharm; 2014 Jan; 71(1):19-25. PubMed ID: 24352178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial dysfunction in the pathogenesis of chemotherapy-induced peripheral neuropathy.
    Trecarichi A; Flatters SJL
    Int Rev Neurobiol; 2019; 145():83-126. PubMed ID: 31208528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-induced peripheral neuropathy in the adult.
    Saad M; Tafani C; Psimaras D; Ricard D
    Curr Opin Oncol; 2014 Nov; 26(6):634-41. PubMed ID: 25229554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology and Therapeutic Perspectives for Chemotherapy-induced Peripheral Neuropathy.
    Avallone A; Bimonte S; Cardone C; Cascella M; Cuomo A
    Anticancer Res; 2022 Oct; 42(10):4667-4678. PubMed ID: 36191965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment and diagnosis of chemotherapy-induced peripheral neuropathy: An update.
    Desforges AD; Hebert CM; Spence AL; Reid B; Dhaibar HA; Cruz-Topete D; Cornett EM; Kaye AD; Urits I; Viswanath O
    Biomed Pharmacother; 2022 Mar; 147():112671. PubMed ID: 35104697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy-induced peripheral neuropathy].
    Noguchi E; Maeda Y
    Gan To Kagaku Ryoho; 2011 Nov; 38(11):1773-6. PubMed ID: 22083183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.